Eleventh Circuit Upholds False Claims Act: Major Ruling on Healthcare Fraud

The Eleventh Circuit's Ruling Upholds False Claims Act Provisions in Healthcare Fraud Case The U.S. Court of Appeals for the Eleventh Circuit has overturned a district court's decision by ruling that the qui tam provisions of the False Claims Act (FCA) do not violate the Constitution’s Appointments Clause. The case, United States ex rel. Zafirov v. Florida Medical Associates, LLC, reopens allegations that healthcare providers inflated Medicare reimbursements through inaccurate diagnosis codes. This ruling reactivates the FCA claim, which alleges fraudulent Medicare billing practices. Notably, the court did not address defendants' additional constitutional arguments regarding the Take Care Clause and the Vesting Clause, remanding these issues to the district court for further consideration.

Background on the False Claims Act

The FCA empowers private individuals, known as relators, to file lawsuits on behalf of the U.S. government against entities suspected of defrauding federal programs. This mechanism, essential for healthcare fraud detection, often involves current or past employees highlighting inappropriate practices like billing and referral arrangements. Previously, a district court jeopardized this tool by declaring relators lack constitutional jurisdiction under Article II. Dr. Clarissa Zafirov, the relator in this case, initiated her suit as a whistleblower against her employer over fraudulent coding practices to enhance Medicare payments. Despite government declination, Zafirov continued autonomously, facing constitutional counterarguments from the defendants concerning her legitimacy as an FCA representative.

Court's Rejection of Appointments Clause Challenge

The Eleventh Circuit dismissed the notion that FCA relators infringe upon the Appointments Clause. The court reasoned that relators do not hold ongoing federal positions; their roles are specific to individual cases, terminate upon conclusion, and receive no government remuneration. The appellate court emphasized that the FCA does not create any official position termed "office of relator," thereby securing the framework through which private whistleblowers may proceed absent direct government intervention.

• Relator Role: Case-specific and temporary involvement without governmental pay.
• FCA Claims: Driven by whistleblowers, often concerning federal healthcare payments.
• Appeal Impact: Reaffirms relators’ legitimacy under the FCA in the Eleventh Circuit.

Implications and Industry Concerns

Healthcare providers in the Eleventh Circuit can no longer dismiss FCA claims due to a relator's lack of formal appointment. This resolution aligns with the Fifth, Sixth, Ninth, and Tenth Circuits, reinforcing the role of private enforcement in tackling fraudulent claims. Relators persist in legal action when the federal government opts out, maintaining potential repercussions for healthcare entities. These developments highlight the ongoing liability risk tied to Medicare Advantage risk adjustments. Incorrect diagnosis codes leading to unjustified federal payments continue to draw FTC scrutiny. Healthcare organizations must reinforce compliance measures around coding, billing, and practices affecting federal reimbursement. By upholding key parts of the FCA, the Eleventh Circuit fortifies this statute's viability as an effective channel for detecting healthcare fraud, an issue paramount to maintaining ethical and financial integrity in federal healthcare programs.